跳至主要内容
临床试验/JPRN-UMIN000029628
JPRN-UMIN000029628已完成4 期

Study for the effect on blood glucose fluctuation by switching from DPP-4 inhibitor to SGLT2 inhibitor or to DPP-4 inhibitor/SGLT2 inhibitor combination tablet in patients with type 2 diabetes. - multicenter, prospective, randomized, open-label, parallel group, comparison study - - The effect on blood glucose fluctuation between DPP-4 inhibitor, SGLT2 inhibitor, and DPP-4 inhibitor/SGLT2 inhibitor combination in patients with type 2 diabetes.

Hokkaido University Hospital0 个研究点目标入组 101 人开始时间: 2017年10月19日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
101

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) hypersensitivity to canagliflozin or teneligliptin/ canagliflozin combination tablet. 2) uncontrolled diabetic retinopathy 3) severe liver dysfunction, renal dysfunction, or heart failure 4) pregnancy, nursing woman or possibly pregnant woman 5) severe diabetic ketosis, diabetic coma 6) severe infection, pre and post operation , severe trauma 7) uncontrolled diet therapy 8) deficiency of insulin secretion 9) BMI < 22kg/m2 10) eGFR < 45ml/min 11) patients who thought to be inappropriate to enter this study for some reasons by physician's judgments

研究者

相似试验